Treatment of deep vein thrombosis with low-molecular-weight heparins: A consensus statement of the Gesellschaft fur Thrombose-und Hamostaseforschung (GTH)

Seminars in Thrombosis and Hemostasis

Volumn 23, Issue 1, 1997, Pages 91-96

  Harenberg, Job ^a   Schmitz Huebner, Ulrich ^a   Breddin, Klaus H ^a   Haas, Sylvia ^a   Heinrich, Fritz ^a   Heinrichs, Christa ^a   Kienast, Jochen ^a   Roebruck, Peter ^a   Theiss, Wolfram ^a   Wenzel, Ernst ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

consensus; Deep vein thrombosis; heparin; low molecular weight heparin; management

Indexed keywords

ANTIINFLAMMATORY AGENT; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN;

ANTICOAGULATION; BED REST; CONFERENCE PAPER; DEEP VEIN THROMBOSIS; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; HOSPITALIZATION; INTRAVENOUS DRUG ADMINISTRATION; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 8244248796     PISSN: 00946176     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-996075     Document Type: Conference Paper

References (28)

1. Caspary L, A Creuzig, K Alexander: Lyseindikation bei BeckenBein-Venenthrombose. Med Klin 90:618-622, 1995.
2. Cook DJ, GH Guyatt, A Laupacis, DL Sackett: Rules of evidence and clinical recommendations on the use of antithrombotic agents. Chest 102(Suppl):305-311, 1992.
3. Hommes DW, A Bura, L Mazzolai, HR Büller, JW ten Cate: Subcutaneous heparin compared with continuous intravenous heparin administration in the initial treatment of deep vein thrombosis. Ann Intern Med 116:279-284, 1992.
4. Koopman MMW, P Prandoni, F Piovella, PA Ockford, DP Brandjes, J Van der Meer, AS Gallus, G Simonneau, CH Chesterman, MH Prins: Treatment of patients with proximalvein thrombosis with intravenous unfractionated heparin in hospital compared with subcutaneous low-molecular-weight heparin out of hospital or with early discharge. N Engl J Med 334:682-687, 1996.
5. Levine M, M Gent, J Hirsh, J Leclerc, D Anderson, J Weitz, JS Ginsberg, AG Turpie, C Demers, M Kovacs: A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein-thrombosis. N Engl J Med 334:677-681, 1996.
6. Duroux P, A Beclere: A randomized trial of subcutaneous low molecular weight heparin (CY 216) compared with intravenous unfractionated heparin in the treatment of deep vein thrombosis. A Collaborative European Multicenter Study. Thromb Haemostas 65:251-256, 1991.
7. Prandoni P, AW Lensing, HR Büller, M Carta, A Cogo, M Vigo, DA Casara, A Ruol, JW ten Cate: Comparison of subcutaneous low molecular weight heparin with intravenous standard heparin in proximal deep vein thrombosis. Lancet 339:441-445, 1992.
8. Janvier G, S Winnock, G Dugrais, A Vallet, E Dardel, JM Serise, S Calen, C Vergnes, F Toulemonde: Treatment of deep venous thrombosis with a very low molecular weight heparin fragment (CY 222). Haemostasis 7:49-58, 1987.
9. Holm HA, B Ly, Handeland GF, U Abildgaard, KE Arnesen, P Gottschalk, V Hoeg, M Aandahl, K Haugen, F Laerum, B Scheel, O Sortland, B Vinje: Subcutaneous heparin treatment of deep venous thrombosis: A comparison of unfractionated and low molecular weight heparin. Haemostasis 16(Suppl 1):30-37, 1986.
10. Albada J, JJ Nieuwenhuis, JJ Sixma: Treatment of acute venous thromboembolism with low molecular weight heparin (Fragmin). Results of a double-blind randomized study. Circulation 80:935-939, 1989.
11. Bratt G, E Törnebohn, S Granqvist, W Aberg, D Lockner: A comparison between low molecular weight heparin (Kabi 2165) and standard heparin in the intravenous treatment of deep venous thrombosis. Thromb Haemostas 54:813-817, 1985.
12. Bratt G, W Aberg, M Johansson, E Törnebohm, S Granqvist, D Lockner: Two daily subcutaneous injections of Fragmin as compared with intravenous standard heparin in the treatment of deep venous thrombosis (DVT). Thromb Haemostas 64:506-510, 1990.
13. Lindmarker P, M Holmström, S Granqvist, H Johnsson: Comparison of once-daily subcutaneous Fragmin with continuous intravenous unfractionated heparin in the treatment of deep vein thrombosis. Thromb Haemostas 72:186-190, 1994.
14. Handeland GF, U Abildgaard, HA Holm, KE Arnesen: Dose adjusted heparin treatment of deep venous thrombosis: A comparison of unfractionated and low molecular weight heparin. Eur J Clin Pharmacol 39:107-112, 1990.
15. Alhenc-Gelas M, C Jestin-Le Guernic, JF Vitoux, A Kher A, M Aiach, JN Fiessinger for the Fragmin-Study Group: Adjusted versus fixed doses of the low-molecular-weight heparin Fragmin in the treatment of deep vein thrombosis. Thromb Haemostas 71:698-702, 1994.
16. Fiessinger JN, M Lopez-Fernandez, E Gatterer, S Granqvist, A Kher, CG Olsson, K Söderberg: Once daily subcutaneous dalteparin, a low molecular weight heparin, for the initial treatment of acute deep vein thrombosis. Thromb Haemostas 76:195-199, 1996.
17. Simonneau G, B Charbonnier, H Decousus, B Planchon, J Ninet, P Sie, M Silsiguen, S Combe: Subcutaneous low molecular weight heparin compared with continuous intravenous unfractionated heparin in the treatment of proximal deep vein thrombosis. Arch Intern Med 153:1541-1546, 1993.
18. Huet Y, G Janvier, PH Bendriss, S Wonnock, G Dugrais, G Freyburger, P Boisseras: Treatment of established venous thromboembolism with enoxaparin: Preliminary report. Acta Chir Scand 556(Suppl):116-120, 1990.
19. Janvier G, G Freyburger, S Winnock, G Dugrais, M Boisseau, P Boissieras: An open trial of enoxaparin in the treatment of deep vein thrombosis of the leg. Haemostasis 21:161-168, 1991.
20. Lopaciuk S, AJ Meissner, S Filipecki, K Zawilska, J Sowier, L Ceisielski, J Korzycki: Subcutaneous low molecular weight heparin versus subcutaneous unfractionated heparin in the treatment of deep vein thrombosis. A Polish multicenter trial. Thromb Haemostas 68:14-18, 1992.
21. Harenberg J, K Huck, H Bratsch, G Stehle, CE Dempfle, K Mall, M Blauth, KH Usadel, DL Heene: Therapeutic application of subcutaneous low-molecular-weight heparin in acute venous thrombosis. Haemostasis 20(Suppl 1):205-219, 1990.
22. Kirchmaier CM, E Lindhoff-Last, D Rubesam, I Scharrer, Z Vigh, G Mosch, H Wolf, HK Breddin: Regression of deep vein thrombosis by i.v. administration of a low molecular weight heparin - Results of a pilot study. Thromb Res 73:337-348, 1994.
23. Hull RD, GE Raskob, GF Pineo, D Green, AA Trowbridge, CG Elliott, RG Lerner, J Hall, T Sparling, HR Bretell: Subcutaneous low molecular weight heparin compared with continuous intravenous heparin in the treatment of proximal vein thrombosis. N Engl J Med 326:975-982, 1992.
24. Siegbahn H, Y-H Shams, J Boberg, H Bylund, HS Neerstrand, P Østergaard, U Hedner: Subcutaneous treatment of deep vein thrombosis with low molecular weight heparin. A dose finding study with LMWH-Novo. Thromb Res 55:767-778, 1989.
25. Notarbartolo A, G Salanitri, G Davi, M Averna, G Barbagallo, I Catalano: Low molecular weight heparin in the short and long-term treatment of deep vein thrombosis in diabetic subjects. Med Praxis 9:1-13, 1988.
26. Zanghi M, V Morici, M Costanzo, L Astuto, G Salanitri: Deep vein thrombosis of the legs: New therapy by means of low molecular weight heparins. J Intern Med Res 16:474-484, 1988.
27. Tedoldi A, F Botticella, MR Maloberti: Antithrombophilic effect of low molecular weight heparins in patients with deep vein thrombosis. Clin Trials Meta-Anal 28:215-225, 1993.
28. Faivre R, Y Neuhart, Y Kieffer, F Apfel, D Magrin, D Didier, F Toulemonde, JP Bassand, JP Maurat: Un nouveau traitement des thromboses veineuses profondes: les fractions de heparine de bas poids moleculaire. Etude randomises. Presse Med 17:197-200, 1988.